“I joined CCRM in 2018 as Operations Manager of Good Manufacturing Practices (GMP) Manufacturing when CCRM’s state-of-the-art GMP-compliant facility was transitioning to an operational phase. Its continued expansion has ensured a seamless technology transfer by reducing manufacturing risks and allowing innovation, scalability, flexibility and customization to produce consistent and reproducible batches. In this time, CCRM has provided me with a unique opportunity to lead the discovery of solutions to potential technical and manufacturing challenges in the reprogramming of pluripotent cells and patient-specific engineered T cell therapy production.”

“I joined CCRM in 2012, very close to its inception. CCRM played a pivotal role in my career development. It allowed me to hone skills in technology diligence, operations and alliance management. It is also where I established many valuable and long-standing relationships with individuals in the cell and gene therapy field. Seeing the success of many seeds planted in those early years has been very rewarding! I have leveraged my learnings at CCRM in the years since, enabling genomic medicines in the context of both therapeutic and tools development.”

“During my time at CCRM, I worked as a Process Development Intern. In this role, I liked that there was a goal that needed to be achieved, and a plan for how to get there. CCRM provided me with a network of connections in the Toronto area, united by a passion for advancing the field. There is a great sense of camaraderie within the CCRM network. As I continue to work toward a PhD in chemical engineering, my experience at CCRM has helped me understand the kinds of work I want to do in my career.”